IVIEW Therapeutics Patents – Insights & Stats (Updated 2023)

IVIEW Therapeutics has a total of 74 patents globally, out of which 28 have been granted. Of these 74 patents, more than 79% patents are active. United States of America is where IVIEW Therapeutics has filed the maximum number of patents, followed by China and Europe. Parallelly, China seems to be the main focused R&D centre and also United States of America is the origin country of IVIEW Therapeutics.

IVIEW Therapeutics was founded in the year 2015. The Company is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.

Do read about some of the most popular patents of IVIEW Therapeutics which have been covered by us in this article and also you can find IVIEW Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over IVIEW Therapeutics patent portfolio.

How many patents does the founder and the CEO of IVIEW Therapeutics have?

The founder John J. Baldwin has 10 patents and CEO Bo Liang (also founder) has 0 patent.

How many patents does IVIEW Therapeutics have?

IVIEW Therapeutics has a total of 74 patents globally. These patents belong to 20 unique patent families. Out of 74 patents, 59 patents are active.

How Many Patents did IVIEW Therapeutics File Every Year?

IVIEW Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantIVIEW Therapeutics Applications FiledIVIEW Therapeutics Patents Granted
20233
2022106
202167
2020173
201921
2018101
201722
2016131
20151
20141
201343
20124

How many IVIEW Therapeutics patents are Alive/Dead?

IVIEW Therapeutics Patent Portfolio

How Many Patents did IVIEW Therapeutics File in Different Countries?

IVIEW Therapeutics Worldwide Patent Filing

Countries in which IVIEW Therapeutics Filed Patents

CountryPatents
United States Of America14
China13
Europe8
Canada6
Japan6
Australia3
Hong Kong (S.A.R.)3
Korea (South)2
Germany2
Israel2
India2
Austria1
Brazil1
Spain1

Where are Research Centres of IVIEW Therapeutics Patents Located?

R&D Centers of IVIEW Therapeutics

10 Best IVIEW Therapeutics Patents

US20140219949A1 is the most popular patent in the IVIEW Therapeutics portfolio. It has received 17 citations so far from companies like Iview Therapeutics, Inc., Firebrick Pharma Limited and Veloce Biopharma Llc.

Below is the list of 10 most cited patents of IVIEW Therapeutics:

Publication NumberCitation Count
US20140219949A117
WO2017074965A113
US10195217B25
US9895382B24
WO2021034421A14
US9308173B23
CN112516084A3
CN111939120A3
WO2019046844A12
WO2018004739A12

What Percentage of IVIEW Therapeutics US Patent Applications were Granted?

IVIEW Therapeutics (Excluding its subsidiaries) has filed 15 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 9 have been granted leading to a grant rate of 90.0%.

Below are the key stats of IVIEW Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for IVIEW Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Venture Partner Llc11100.00%
Edward T Wei466.67%

What are IVIEW Therapeutics key innovation segments?

What Technologies are Covered by IVIEW Therapeutics?

The chart below distributes patents filed by IVIEW Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where IVIEW Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has IVIEW Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by IVIEW Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.